FDA Drug Recalls

Recalls / Class II

Class IID-0515-2016

Product

Lorazepam 2 mg/mL Inj., Qty: 1 mL Vial, MFG by: West-Ward Pharma, Eatontown, NJ 07724, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0316-01

Affected lot / code info
LOT#: B0085124-051915, B0086919-052815, Exp 12/01/2016; B0089280-061215, B0090023-061915, B0089996-061915, B0091581-070715, B0091564-070715, B0091515-070715, Exp 01/01/2017; B0094980-080415, B0094965-080415, B0097515-082415, B0100639-091415, B0100611-091415, Exp 03/01/2017; B0100933-091515, B0107165-101915, B0107118-101915, Exp 06/01/2017.

Why it was recalled

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Recalling firm

Firm
RemedyRepack Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
625 Kolter Dr Ste 4, N/A, Indiana, Pennsylvania 15701-3571

Distribution

Quantity
1625 Vials
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-11-11
FDA classified
2015-12-04
Posted by FDA
2015-12-16
Terminated
2016-11-01
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0515-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.